Dihexa activates the c-Met receptor pathway, which is also involved in certain cancers creating a theoretical oncogenic concern
Research comparing MT-II with MT-1 and native -MSH has established that cyclic lactam backbone constraint shifts melanocortin receptor subtype selectivity toward MC3R and MC4R relative to linear peptide analogues and with MT-II showing substantially enhanced potency at MC3R and MC4R relative to its potency ratio at MC1R compared with the linear MT-1
Driven by clinical feedback and material science to make bonding day faster, easier, and more predictable
In early June I restarted on the doses left in the pen, back at the 2.5mg microdose, purely as maintenance while the leg heals I'm at just under 94 kg one week back on
For broader context, research discussions around cortisol and GLP-1 may help explain why stress biology, appetite signaling, and metabolic regulation often overlap during menopause